Literature DB >> 33257871

What could a new disease activity score for polymyalgia rheumatica do better?

Burkhard F Leeb1,2.   

Abstract

Entities:  

Mesh：

Year:  2021        PMID： 33257871     DOI： 10.1038/s41584-020-00550-6

Source DB:  PubMed          Journal:  Nat Rev Rheumatol        ISSN： 1759-4790            Impact factor:   20.543


× No keyword cloud information.
  2 in total

1.  Reply to: What could a new disease activity score for polymyalgia rheumatica do better?

Authors:  Dario Camellino; Eric L Matteson; Frank Buttgereit; Christian Dejaco
Journal:  Nat Rev Rheumatol       Date:  2021-03       Impact factor: 20.543

2.  PolyMyalgia Rheumatica treatment with Methotrexate in Optimal Dose in an Early disease phase (PMR MODE): study protocol for a multicenter double-blind placebo controlled trial.

Authors:  Diane E Marsman; Thomas E Bolhuis; Nathan den Broeder; Alfons A den Broeder; Aatke van der Maas
Journal:  Trials       Date:  2022-04-15       Impact factor: 2.728
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.